Login to Your Account

Scottish Start-up UB Pharma to Deliver UPS Drug Targets

By Nuala Moran
Staff Writer

Tuesday, June 11, 2013

LONDON – A £9.3 million (US$14.43 million) publicly funded ubiquitin research program has overcome difficulties in drugging those key protein recycling targets, leading to the formation of UB Pharma Ltd., which has now set out to raise £4 million to £6 million to take the lead candidates through to the clinic.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription